2009 Pittcon Final Program - Pittcon Web Archives

Pittcon 2009 Technical Program
1:35 (1420-1) Direct Observation of Atomic Arrangement of
Surface by Holography and Stereo-Photography HIROSHI DAIMON, Nara
Institute of Science and Technology (NAIST), Fumihiko Matsui, Tomohiro
Matsushita
2:10 (1420-2) In situ TEM and Multidimensional Electron
Tomography on Nanostructured Materials XIAO FENG ZHANG, Hitachi
High Technologies America, Konrad Jarausch
2:45 (1420-3) An Electron Microscope for Nanotechnology: To See
Something Small You'll Need Something Big MICHAEL MILLER KERSKER,
JEOL USA
3:20 (1420-4) Latest Developments in X-ray Photoelectron
Spectroscopy and Their Application to Nanosurfaces DAVID SURMAN,
Kratos Analytical Inc.
3:55 (1420-5) The Future of Molecular Spectroscopy for the
Advancement of Nanotechnology ADAM MATTHEW GILMORE, HORIBA
WORKSHOP Session 1430
Case Studies in the Stability of Drug Substances and Drug
Products - arranged by Brian K Nunnally, Wyeth
Tuesday Afternoon, Room S501d
Brian K Nunnally, Wyeth, Presiding
1:30 Introductory Remarks - Brian K Nunnally
1:35 (1430-1) Stress Stability Studies for Protein Therapeutics: A
Case Study JAMIE MR MOORE, Genentech
2:10 (1430-2) A Case Study in Stability Study Design and
Execution to Meet Complex Submission Requirements JEFFREY
KETTLER, Wyeth
2:45 (1430-3) Opportunities in Pharmaceutical Off-
Shoring/Outsourcing BARRY JAY SCHEER, Bristol-Myers Squibb, Pankaj
Shah, Jingpin Jia, Kalpana Chaturvedi
3:20 (1430-4) Following the Stability of a Clinical Vaccine Through
its Intermediates, Drug Substance and Drug Product BRIAN K NUNNALLY,
Wyeth
3:55 Panel Discussion
WORKSHOP Session 1440
Your Questions Answered about Certified Reference Materials -
arranged by Thomas J Mancuso and Ralph Obenauf, SPEX CertiPrep Group
Tuesday Afternoon, Room S501bc
Thomas J Mancuso, SPEX CertiPrep Group LLC, Presiding
1:30 Introductory Remarks - Thomas J Mancuso and
Ralph Obenauf
1:35 (1440-1) A Stable Sulfide Standard: An Alternative to Zinc
Acetate Preservation MARK HAMMERSLA, NSI Solutions
2:05 (1440-2) Reference Materials (Certified or Not) for the
Pharmaceutical Industry WILLIAM F KOCH, US Pharmacopeia, Johanna M
Smeller
2:35 (1440-3) Preparation of Reference Materials in the Food
Testing Industry CURTIS JAMES WOOD, ERA
3:05 Recess
3:20 (1440-4) The Need, Use and Implementation of Traceability
and Uncertainty Measurements in an Analytical Testing Laboratory
LANCE BOYNTON, Absolute Standards, Inc.
3:50 (1440-5) Relevance of ISO 17025 and ISO Guide 34 to
Chemical Reference Materials Manufacturers THOMAS J MANCUSO, SPEX
CertiPrep Group
4:20 Panel Discussion
ORGANIZED CONTRIBUTED
Session 1450
SESSION
Analytical Diagnostics of Disease from Cellular Signals -
arranged by Anna Brajter-Toth, University of Florida
Tuesday Afternoon, Room S405a
Anna Brajter-Toth, University of Florida, Presiding
1:30 (1450-1) Monitoring Apoptosis Induction and Inhibition by
Intracellular Multi-Parameter Fluorescence DIMITRI PAPPAS, Texas Tech
University
1:50 (1450-2) Analysis of Single Cells by Microseparation Methods
NANCY ALLBRITTON, University of North Carolina, Chris Sims, Sumith
Kottegoda
2:10 (1450-3) Detecting Metabolic Rearrangements in Diseased
Tissues Using Capillary LC-MS ROBERT T KENNEDY, University of
Michigan
2:30 (1450-4) Microfluidics: Enabling Diagnostics via Cellular
Analysis DANA SPENCE, Michigan State University
2:50 Recess
3:05 (1450-5) Mapping Receptors on Cancer Cell Surface
WEIHONG TAN, University of Florida, Yan Chen, Michael Mavros
3:25 (1450-6) Electrocatalytic Detection of Cancer Biomarkers
using Nanostructured Microelectrodes SHANA O KELLEY, University of
Toronto
3:45 (1450-7) Elucidating Cancer Cell Metabolism using Scanning
Electrochemical Microscopy and Microfluidic Physiometry DAVID
CLIFFEL, Vanderbilt University, Jeremy Wilburn, Madalina Ciobanu
4:05 (1450-8) Metabolic Biomarkers of Cellular Oxidative Stress
ANNA BRAJTER-TOTH, University of Florida, Mehjabin Kathiwala, Sergey
Zharikov
ORGANIZED CONTRIBUTED
Session 1460
SESSION
Emerging Applications and Technologies for the Identification
of Genotoxic Impurities - arranged by Arindam Roy, Covidien and Mike
S Lee, Milestone Development Services
Tuesday Afternoon, Room S404d
Mike S Lee, Milestone Development Services, Presiding
1:30 (1460-1) Business Impact of FDA Structural Alerts DAVID
WAYNE BERBERICH, Covidien
1:50 (1460-2) Detection of Trace Level Genotoxic Impurities in
Early Phase Pharmaceutical Development using LC-MS and GC-MS
Techniques DAVID ROBBINS, Eli Lilly and Company
2:10 (1460-3) Impurities: Finding and Defining the Uninvited
Guests ROBERT IAN ELLIS, Applied Biosystems/MDS Analytical
Technologies, Alina Dindyal-Popescu, Tanya Gamble
2:30 (1460-4) Identification and Characterization of a Novel
Delivery Molecule for a Clandestine PDE-5 Inhibitor Drug in a Dietary
Supplement by LC-MS n , FT-MS and NMR JAMES NEAL-KABABICK, Flora
Research Laboratories, Ed George
2:50 Recess
3:05 (1460-5) Nanospray Ionization MS for the Analysis of Related
Chemical Species in Complex Matricies: Investigation of Equimolar
Response and Extended Dynamic Range GARY A VALASKOVIC, New
Objective Inc.
3:25 (1460-6) Case Study: Development of Highly Sensitive
Analytical Method to Determine Low ppm Level of Genotoxic Impurities in
Organic Synthesis Processes JIE ZHENG, Abbott Laboratories, Wayne A
Pritts, Shuhong Zhang, Steve Wittenberger
3:45 (1460-7) Evaluation of the Importance of Ionization Efficiency,
Ion Transmission and Sensitivity for Impurity Profiling Applications using
Multistage Mass Spectrometry DAVID A WEIL, Agilent Technologies
4:05 (1460-8) Rapid Determination of Impurities utilizing Direct
Analysis in Real Time (DART) Mass Spectrometry with Activated Surfaces
BRIAN MUSSELMAN, IonSense, Inc., Elizabeth Crawford, Robert Cody
Tuesday, p.m., March 10
95